DATE
October 3, 2025

Anne-Goldfeld-MD-Blog-1

The National Foundation for Infectious Diseases (NFID) will celebrate 3 outstanding public health heroes who have made significant and lasting contributions to public health at the 2025 NFID Annual Awards Gala and Silent Auction, a black-tie fundraising event on October 16, 2025, in Washington, DC. This is the third in a 3-part series profiling the inspirational work of the 2025 awardees.

2025 Jimmy and Rosalynn Carter Humanitarian Award

Anne E. Goldfeld, MD, a visionary physician-scientist and humanitarian, will receive the 2025 Jimmy and Rosalynn Carter Humanitarian Award in recognition of her groundbreaking contributions that have helped change the course of 2 of the deadliest epidemics of our time: tuberculosis (TB) and HIV/AIDS.

Growing up in Los Angeles, Anne developed a deep commitment to justice and human rights at an early age. She attended Brown University and the University of California, Berkeley, and received her medical degree at the Albert Einstein College of Medicine. While training as an internist and infectious disease specialist at Massachusetts General Hospital, she volunteered on the Thai-Cambodian border, providing care for refugees who had fled the Khmer Rouge genocide. After her postdoctoral training in molecular biology at Harvard, she returned to the camps as the team leader of a medical program in one of the largest encampments in an active war zone, where she was first exposed to the devastation caused by landmines. Seeing the landmine crisis as a preventable and medical catastrophe, she systemically documented their toll, mounted a first landmine prevention program, and became one of the first voices to call for a global ban on landmines.

A visionary leader at the intersection of science and service, in parallel with her work as a physician-scientist at Harvard Medical School, Goldfeld co-founded transformative treatment and research programs in Cambodia for TB, drug-resistant TB, and HIV—and later for drug-resistant TB in Ethiopia—bringing care to some of the world’s most underserved populations. Applying her scientific expertise to TB and HIV, her work has provided a new understanding behind the immune response to TB and TB/HIV co-infection and changed global treatment guidelines for HIV/TB treatment, which is estimated to have saved more than 150,000 lives annually over the last 14 years.

She is a professor of medicine and pediatrics at Harvard Medical School; senior investigator in the Program on Cellular and Molecular Medicine at Boston Children’s Hospital where her research laboratory is located; professor of immunology and infectious disease at the Harvard TH Chan School of Public Health; a physician in the Infectious Disease Division of Brigham and Women’s Hospital; and co-founder of the Cambodian Health and Global Health Committees.

The fusion of her scientific and clinical work with humanitarian efforts has led to breakthroughs in treatment and research and to bringing access and scaling up of care to treat TB and HIV. She has been described as having a unique ability to see connections overlooked by others. NFID is proud to recognize her work as physician-scientist, visionary, and humanitarian who has made a profound impact on global public health and has contributed discoveries that have saved countless lives.

Join NFID to Honor Anne E. Goldfeld, MD

The 2025 NFID Annual Awards Gala and Silent Auction honors inspirational public health heroes who have helped protect the lives of millions. Join us to celebrate 3 outstanding individuals and support the important work of NFID at the fundraising gala on October 16, 2025, at the Omni Shoreham Hotel in Washington, DC.

Tickets and sponsorship opportunities are available online at www.nfid.org/2025Gala.

All contributions support the NFID vision of healthier lives for all through the effective prevention and treatment of infectious diseases.

For additional perspectives from Anne E. Goldfeld, MD, listen to the NFID Infectious IDeas podcast episode, Hope, Healing, and Human Rights:

Anne Goldfeld podcast episode feature image


To join the conversation and get the latest news on infectious diseases: